PolyPid Ltd.
corporate_fare Company Profile
PolyPid Ltd. (NASDAQ:PYPD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for PYPD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-01, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for PYPD spans 6-K, 20-F.
Recent high-impact activity:
- EMA Validates PolyPid's D-PLEX100 Marketing Application, Starting Formal EU Review
- PolyPid Regains European Rights to D-PLEX100 After ADVANZ PHARMA Deal Ends
- PolyPid Q2: $15.6M Loss, Going Concern Doubt, but Azurity Deal Brings $30M Near-Term
- PolyPid Reports Q2 2026 Results: $6.6M Cash, $30M Milestone Achieved, Cash Runway into 2028
- PolyPid Posts $7.8M Q2 Loss, $6.6M Cash; $5.8M Raised in July Extends Runway to Q2 2027
Financial Snapshot
Short Interest & Short Volume
1.11 days to coverFINRA reported short interest of 130,353 shares in PYPD as of the September 15, 2026 settlement, a 33.1% decrease from the prior period — about 1.1 days to cover at its recent average daily volume. On October 2, 2026, 48.5% of PYPD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
PYPD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.